Providing financial technologies to transform Drug Development

About Futura

Futura Medical are UK based innovative R&D company with a pipeline of products in late-stage development. They area pharmaceutical company developing a portfolio of innovative products based on their proprietary, transdermal DermaSys® technology.

Futura are transitioning from Sage 50 as they don’t have any consolidation functionality or an ability to track inventory accurately. They are looking for a system that can handle automatic consolidation and streamline workflows.

‍

Objectives

Futura Medical had two key objectives for a new system, they wanted to make a time saving by streamlining processes to remove duplication (purchase orders are currently processed via e-mail approval) and reduce excel based work, that forms a large part of their management reporting process.

‍

Futura + Sage Intacct

Through Sage Intacct, Futura have made significant time savings transitioning away from the use of excel spreadsheets, where they were manually processing Finance tasks manually.

Futura also now have more budget control via Sage Intacct, taking advantage of budget planning and reporting capabilities.

Futura also plan to use Sage Intacct inventory capability as a future phase, which will allow them to batch track the drugs that they produce and sell.

‍